Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelets.

J N George1

  • 1Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City 73190, USA. Jim-George@OUHSC.edu

Lancet (London, England)
|May 9, 2000
PubMed
Summary
This summary is machine-generated.

Platelets are vital for blood clotting and preventing bleeding. Understanding platelet function and thrombopoietin signaling is key to treating bleeding disorders and thrombotic diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry.

Hamostaseologie·2013
Same author

The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care.

Hamostaseologie·2013
Same author

Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP).

Journal of thrombosis and haemostasis : JTH·2010
Same author

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder.

Bone marrow transplantation·2008
Same author

Management of patients with refractory immune thrombocytopenic purpura.

Journal of thrombosis and haemostasis : JTH·2006
Same author

An evaluation of cyclosporine alone for the treatment of early recurrences of thombotic thrombocytopenic purpura.

Journal of thrombosis and haemostasis : JTH·2006
Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Hematology
  • Cell Biology
  • Biochemistry

Background:

  • Platelets, originating from megakaryocytes, are crucial for hemostasis and thrombotic conditions.
  • Thrombopoietin regulates megakaryocyte development by binding to c-mpl receptors on platelets and megakaryocytes.
  • Platelet membrane glycoproteins facilitate adhesion to subendothelial tissues and aggregation, forming hemostatic plugs.

Purpose of the Study:

  • To elucidate the role of platelets in hemostasis and thrombotic disorders.
  • To understand the mechanism of megakaryocyte development regulated by thrombopoietin.
  • To highlight the therapeutic potential of platelet function modulation.

Main Methods:

  • Review of existing literature on platelet biology and function.
  • Analysis of the thrombopoietin signaling pathway.

Related Experiment Videos

  • Examination of the role of platelet membrane glycoproteins in adhesion and aggregation.

    • Main Results:

    • Platelets play a dual role in hemostasis and thrombosis.
    • Thrombopoietin-c-mpl interaction is central to megakaryocyte development.
    • Platelet dysfunction or low platelet count leads to bleeding.
    • Platelet membrane glycoproteins are essential for clot formation.

    Conclusions:

    • Platelet function is critical for maintaining vascular integrity and preventing excessive bleeding.
    • Targeting thrombopoietin or platelet function offers therapeutic strategies for cardiovascular and cerebrovascular diseases.
    • Further research into platelet biology can lead to novel treatments for bleeding and clotting disorders.